Balance Ophthalmics Tags Norbert Lowe as Chief Commercial Officer

Published on July 9, 2026
SIOUX FALLS, S.D.—Balance Ophthalmics, a medical device company advancing non-pharmacological, non-surgical treatment options for glaucoma, has announced the appointment of Norbert Lowe as chief commercial officer, effective immediately. In this new role, Lowe will lead the company’s commercial strategy and execution as it prepares to expand awareness and adoption of the FSYX (pronounced “physics”) Ocular Pressure Adjusting Pump (OPAP). Balance said this appointment comes at a pivotal time, following the FDA 510(k) clearance of the wireless-enabled next-generation FSYX system in May 2026 and ahead of anticipated broader commercialization.
Continue reading on website
Other news

Rudy Project Acquires North American Distributor, Names Jaclyn Mayer General Manager of Rudy Project North America

July 9, 2026
TREVISO, Italy and SAN CLEMENTE, Calif.—Rudy Project, an Italian leader in the design and manufacturing of high-performance sports helmets and eyewear, has acquired ownership of Rudy Project North America L.P., its exclusive North American distributor, as of February 2026. Rudy Project will now operate directly in the U.S. market, the company said. This strategic operation also includes the Caribb

CooperVision Strengthens Professional Affairs, Myopia Management Functions With Leadership Appointments

July 9, 2026
ROCHESTER, N.Y.—CooperVision, a division of CooperCompanies (Nasdaq:COO) and a leading manufacturer of contact lenses, has announced the promotion of Jennifer Palombi, OD, FAAO, to director of professional affairs, Americas, and Felicia Timmermann, OD, MS, FAAO, to senior advisor, myopia management, U.S. Both appointments are effective immediately and reflect what the company noted is a “continued